Maria Kłopocka

Statistics

Publications

Citations

1.7K

H-Index

Active since

2004

Affiliations

Nicolaus Copernicus University(Current)

Collegium Medicum in Bydgoszcz

Medical University of Lublin

Poznan University of Medical Sciences

University of California San Diego

Maria Kłopocka is an author at Nicolaus Copernicus University specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and gastrointestinal inflammation.

ORCID

Publications per year

2004–2024

Publications

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

Séverine Vermeire, Stefan Schreiber, Robert Petryka et al. · The Lancet · 2016 · 439 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial

Séverine Vermeire, William J. Sandborn, Silvio Danese et al. · The Lancet · 2017 · 197 citations

Life Sciences, Immunology, Pharmacotherapy +14

Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study

William J. Sandborn, Scott D. Lee, Dino Tarabar et al. · Gut · 2017 · 107 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

Laurent Peyrin‐Biroulet, Jessica R. Allegretti, David T. Rubin et al. · Gastroenterology · 2023 · 92 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study

Silvio Danese, Maria Kłopocka, Ellen Scherl et al. · Clinical Gastroenterology and Hepatology · 2021 · 91 citations · Full text

Life Sciences, Immunology, Autoimmunity +12

1–5 of 32